HARVARD BIOSCIENCE INC (HBIO) Forecast, Price Target & Analyst Ratings
NASDAQ:HBIO • US4169061052
0.5291 USD
0 (-0.19%)
Last: Mar 11, 2026, 10:58 AM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HARVARD BIOSCIENCE INC (HBIO).
Forecast Snapshot
Consensus Price Target
$2.04
+ 285.56% Upside
Next Earnings Forecast
Release DateMar 12, 2026
PeriodQ4 / 2025
EPS Estimate$0.04
Revenue Estimate23.562M
ChartMill Buy Consensus
80.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$2.04
Upside
+ 285.56%
From current price of $0.53 to mean target of $2.04, Based on 8 analyst forecasts
Low
$2.02
Median
$2.04
High
$2.10
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
8 Wall Street analysts provided a forecast for the next 12 months for HBIO. The average price target is 2.04 USD. This implies a price increase of 285.56% is expected in the next year compared to the current price of 0.5291.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
HBIO was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about HBIO.
In the previous month the buy percentage consensus was at a similar level.
HBIO was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-09-10 | Benchmark | Maintains | Speculative Buy -> Speculative Buy |
| 2025-05-13 | Benchmark | Maintains | Speculative Buy -> Speculative Buy |
| 2025-04-09 | Keybanc | Downgrade | Overweight -> Sector Weight |
| 2025-04-08 | Keybanc | Downgrade | Overweight -> Sector Weight |
| 2025-03-24 | Benchmark | Maintains | Speculative Buy -> Speculative Buy |
| 2023-06-22 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2023-04-26 | Keybanc | Maintains | Overweight |
| 2023-04-26 | Benchmark | Maintains | Buy |
| 2023-03-10 | Benchmark | Reiterate | Buy |
| 2022-11-09 | Keybanc | Maintains | Overweight |
| 2022-08-05 | Keybanc | Maintains | Overweight |
Next Earnings Forecast Details
Next Earnings Details
Release DateMar 12, 2026
PeriodQ4 / 2025
EPS Estimate$0.04
Revenue Estimate23.562M
Revenue Q2Q-4.05%
EPS Q2Q-40.50%
Number of Analysts4
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
HBIO is expected to report earnings on 3/12/2026. The consensus EPS estimate for the next earnings is 0.04 USD and the consensus revenue estimate is 23.56M USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 113.3M -4.71% | 112.25M -0.93% | 94.135M -16.14% | 87.618M -6.92% | 94.452M 7.80% | 98.43M 4.21% | |
| EBITDA YoY % growth | 2.87M -73.96% | 9.283M 223.45% | 1.781M -80.81% | 8.058M 352.44% | 12.597M 56.33% | 14.892M 18.22% | |
| EBIT YoY % growth | -4.7M -238.24% | 2.285M 148.62% | -5.376M -335.27% | -50.184M -833.48% | 3.774M 107.52% | 7.242M 91.89% | |
| Operating Margin | -4.15% | 2.04% | -5.71% | -57.28% | 4.00% | 7.36% | |
| EPS YoY % growth | 0.12 -52.00% | 0.15 25.00% | 0.06 -60.00% | 0.03 -49.00% | 0.10 216.67% | 0.20 110.53% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.04 -40.50% | -0.01 49.00% | 0.03 406.00% | 0.03 | 0.04 14.29% |
| Revenue Q2Q % growth | 23.562M -4.05% | 21.675M -0.45% | 23.205M 13.47% | 23.664M 14.92% | 25.755M 9.31% |
| EBITDA Q2Q % growth | 3.315M -55.11% | 1.377M 4,341.94% | 3.111M 25.34% | 3.315M -31.51% | 4.437M 33.85% |
| EBIT Q2Q % growth | 1.122M 392.11% | -765K 52.89% | 918K 216.35% | 1.122M 357.96% | 2.193M 95.45% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
50.37%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
0.97%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
360.00%
EBIT Next 5 Year
N/A
HARVARD BIOSCIENCE INC / HBIO Forecast FAQ
What is the average price target for HARVARD BIOSCIENCE INC (HBIO) stock?
8 analysts have analysed HBIO and the average price target is 2.04 USD. This implies a price increase of 285.56% is expected in the next year compared to the current price of 0.5291.
Can you provide the upcoming earnings date for HARVARD BIOSCIENCE INC?
HARVARD BIOSCIENCE INC (HBIO) will report earnings on 2026-03-12, before the market open.
Can you provide the consensus estimates for HARVARD BIOSCIENCE INC next earnings?
The consensus EPS estimate for the next earnings of HARVARD BIOSCIENCE INC (HBIO) is 0.04 USD and the consensus revenue estimate is 23.56M USD.
Can you provide the expected long term growth rate for HARVARD BIOSCIENCE INC stock?
The expected long term growth rate for HARVARD BIOSCIENCE INC (HBIO) is 0.97%.